[1] |
Katirachi SK, Grønlund MP, Jakobsen KK, et al. The prevalence of HPV in oral cavity squamous cell carcinoma[J]. Viruses, 2023, 15(2): 451.
|
[2] |
Pillai J, Chincholkar T, Dixit R, et al. A systematic review of proteomic biomarkers in oral squamous cell cancer[J]. World J Surg Oncol, 2021, 19(1): 315.
doi: 10.1186/s12957-021-02423-y
pmid: 34711249
|
[3] |
陈美波, 陈清梅, 张彧. 癌抗原125中性粒细胞明胶酶相关脂质运载蛋白及人附睾蛋白4在子宫内膜癌患者血清中的表达水平及诊断价值[J]. 中国妇幼保健, 2022, 37(10): 1881-1883.
|
[4] |
王晓诺, 包香香, 陈芳. 甲壳质酶蛋白40、糖类抗原125和人附睾蛋白4在子宫内膜癌病人血清中的表达及诊断价值[J]. 安徽医药, 2021, 25(9): 1766-1770.
|
[5] |
Almangush A, Mäkitie AA, Triantafyllou A, et al. Staging and grading of oral squamous cell carcinoma: An update[J]. Oral Oncol, 2020, 107: 104799.
|
[6] |
Kato MG, Baek CH, Chaturvedi P, et al. Update on oral and oropharyngeal cancer staging-international perspectives[J]. World J Otorhinolaryngol Head Neck Surg, 2020, 6(1): 66-75.
|
[7] |
Stern PL, Dalianis T. Oropharyngeal squamous cell carcinoma treatment in the era of immune checkpoint inhibitors[J]. Viruses, 2021, 13(7): 1234.
|
[8] |
Che K, Han WK, Zhang MX, et al. Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma[J]. Oncol Lett, 2021, 21(2): 148.
doi: 10.3892/ol.2020.12409
pmid: 33552266
|
[9] |
Crescenzi E, Leonardi A, Pacifico F. NGAL as a potential target in tumor microenvironment[J]. Int J Mol Sci, 2021, 22(22): 12333.
|
[10] |
Rahimi S, Roushandeh AM, Ahmadzadeh E, et al. Implication and role of neutrophil gelatinase-associated lipocalin in cancer: Lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types[J]. Mol Biol Rep, 2020, 47(3): 2327-2346.
doi: 10.1007/s11033-020-05261-5
pmid: 31970626
|
[11] |
Schor AM, Woolston AM, Kankova K, et al. MigrationStimulating factor (MSF): Its role in the tumour microenvironment[J]. Adv Exp Med Biol, 2021, 1329: 351-397.
doi: 10.1007/978-3-030-73119-9_18
pmid: 34664248
|
[12] |
Caldeira PC, Vieira ÉLM, Sousa AA, et al. Immunophenotype of neutrophils in oral squamous cell carcinoma patients[J]. J Oral Pathol Med, 2017, 46(9): 703-709.
doi: 10.1111/jop.12575
pmid: 28370402
|
[13] |
Hiromoto T, Noguchi K, Yamamura M, et al. Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: Relation to cell differentiation[J]. Oncol Rep, 2011, 26(6): 1415-1421.
doi: 10.3892/or.2011.1429
pmid: 21874256
|
[14] |
Rusak A, Jabłońska K, Dzięgiel P. The role of YKL-40 in a cancerous process[J]. Postepy Hig Med Dosw (Online), 2016, 70(0): 1286-1299.
pmid: 28026831
|
[15] |
Zhao T, Su ZP, Li YC, et al. Chitinase-3 like-protein-1 function and its role in diseases[J]. Signal Transduct Target Ther, 2020, 5(1): 201.
|
[16] |
Pouyafar A, Heydarabad MZ, Mahboob S, et al. Angiogenic potential of YKL-40 in the dynamics of tumor niche[J]. Biomedecine Pharmacother, 2018, 100: 478-485.
|
[17] |
Roslind A, Johansen JS, Christensen IJ, et al. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival[J]. Int J Cancer, 2008, 122(4): 857-863.
pmid: 17957792
|
[18] |
Suwanwela J, Osathanon T. Inflammation related genes are upregulated in surgical margins of advanced stage oral squamous cell carcinoma[J]. J Oral Biol Craniofac Res, 2017, 7(3): 193-197.
doi: 10.1016/j.jobcr.2017.05.003
pmid: 29123999
|